From 9 Takeaways from Boston’s Life Science Disruptors:

Disruptors, Exter and Leschly

Disruptors, Exter and Leschly—

Neil Exter and Nick Leschly discussing the history of Bluebird Bio.

Underwriters and Partners

Xconomy Insight

Sponsored · Webinar
Oct. 28 – Accelerating COVID-19 Drug Discovery: Qualified Assays for Proinflammatory Cytokines
How Functional Cell-based Assays Support Clinical Programs Managing Proinflammatory Cytokines Associated with High Mortality
Eurofins DiscoverX

From Our Editors · Special Report
Xcelerating Life Sciences San Francisco: Special Report
The AI, Big Data, and R&D Boom

Sponsored · Whitepaper
What’s Next in Neuroscience Therapies
New approaches & tech are on the horizon that could change how researchers and clinicians approach brain and neurological disorders

Xconomy on Demand

We offer a number of ways to subscribe for free!